IDEAYA Biosciences (IDYA) News Today $17.31 +0.21 (+1.23%) As of 05/15/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock IDYA Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Janus Henderson Group PLC Acquires 695,263 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Janus Henderson Group PLC increased its stake in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 13.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 5,857,639 shares of the company's stock after acquiMay 15 at 5:40 AM | marketbeat.comEnsign Peak Advisors Inc Cuts Stock Holdings in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Ensign Peak Advisors Inc reduced its stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 7.8% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 564,217 shares of the company's stock after selling 47,597 shares during the periMay 14 at 5:26 AM | marketbeat.comThe Manufacturers Life Insurance Company Sells 15,785 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA)The Manufacturers Life Insurance Company lessened its stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 16.0% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 82,602 shares of theMay 13 at 4:17 AM | marketbeat.comFY2025 EPS Estimates for IDYA Cut by Cantor FitzgeraldIDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) - Investment analysts at Cantor Fitzgerald cut their FY2025 earnings estimates for IDEAYA Biosciences in a report issued on Thursday, May 8th. Cantor Fitzgerald analyst L. Watsek now expects that the company will post earnings of ($2.62) per shMay 13 at 3:14 AM | marketbeat.comDimensional Fund Advisors LP Has $8.91 Million Stock Holdings in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Dimensional Fund Advisors LP lowered its stake in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 7.9% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 346,765 shares of the company's stock after selling 2May 12, 2025 | marketbeat.comResearch Analysts Set Expectations for IDYA FY2025 EarningsMay 12, 2025 | americanbankingnews.com16,769 Shares in IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Acquired by Raymond James Financial Inc.Raymond James Financial Inc. acquired a new stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 16,769 shares of the company's stock, valued at approximaMay 12, 2025 | marketbeat.comLeerink Partnrs Has Positive Outlook of IDYA Q2 EarningsIDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) - Analysts at Leerink Partnrs increased their Q2 2025 earnings per share (EPS) estimates for shares of IDEAYA Biosciences in a research note issued to investors on Tuesday, May 6th. Leerink Partnrs analyst A. Berens now expects that the companyMay 11, 2025 | marketbeat.comBrokers Offer Predictions for IDYA Q2 EarningsIDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) - Wedbush issued their Q2 2025 earnings per share (EPS) estimates for IDEAYA Biosciences in a note issued to investors on Tuesday, May 6th. Wedbush analyst R. Driscoll expects that the company will post earnings of ($0.88) per share for the quaMay 11, 2025 | marketbeat.comQ2 Earnings Estimate for IDYA Issued By WedbushMay 11, 2025 | americanbankingnews.comLeerink Partnrs Has Positive Forecast for IDYA Q2 EarningsMay 11, 2025 | americanbankingnews.comA Look At The Fair Value Of IDEAYA Biosciences, Inc. (NASDAQ:IDYA)May 10, 2025 | finance.yahoo.comDAFNA Capital Management LLC Purchases 27,417 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA)DAFNA Capital Management LLC grew its holdings in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 5.8% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 498,827 shares of the company's stock after purchasing an additional 27,417 sharMay 10, 2025 | marketbeat.comIDEAYA Biosciences, Inc. (NASDAQ:IDYA) Shares Purchased by Deerfield Management Company L.P. Series CDeerfield Management Company L.P. Series C grew its holdings in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 5.5% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 2,736,000 shares of the company's stockMay 10, 2025 | marketbeat.comCrestline Management LP Buys 70,571 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Crestline Management LP raised its position in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 283.9% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 95,428 shares of the company's stock after acquiring an additiMay 10, 2025 | marketbeat.comBrevan Howard Capital Management LP Increases Stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Brevan Howard Capital Management LP increased its stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 210.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 44,539 shMay 10, 2025 | marketbeat.comAxa S.A. Grows Position in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Axa S.A. grew its stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 20.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 249,702 shares of the company's stock after buying an additional 41May 9, 2025 | marketbeat.comIDEAYA Biosciences (NASDAQ:IDYA) Announces Earnings ResultsIDEAYA Biosciences (NASDAQ:IDYA - Get Free Report) announced its quarterly earnings data on Tuesday. The company reported ($0.82) earnings per share for the quarter, missing the consensus estimate of ($0.75) by ($0.07). During the same quarter in the previous year, the company posted ($0.53) earnings per share.May 8, 2025 | marketbeat.comVoya Investment Management LLC Sells 281,664 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Voya Investment Management LLC decreased its holdings in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 84.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 52,313 shares of the company's stock afterMay 8, 2025 | marketbeat.comIDEAYA Biosciences (NASDAQ:IDYA) Trading Down 10.2% Following Weak EarningsMay 8, 2025 | americanbankingnews.comIDEAYA Biosciences, Inc. Reports First Quarter 2025 Financial Results and Provides Business ...May 6, 2025 | gurufocus.comIDEAYA Biosciences, Inc. Reports First Quarter 2025 Financial Results and Provides Business UpdateMay 6, 2025 | gurufocus.comAvidity Partners Management LP Sells 246,300 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Avidity Partners Management LP decreased its stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 17.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,126,700 shares of the company's stock after sellingMay 6, 2025 | marketbeat.comIDEAYA Biosciences, Inc. Reports First Quarter 2025 Financial Results and Provides Business UpdateMay 6, 2025 | prnewswire.comIDEAYA Biosciences Announces US FDA IND-Clearance for IDE849, a Potential First-in-Class DLL3 TOP1 ADC, for a Phase 1 Study in Solid TumorsMay 6, 2025 | prnewswire.comHsbc Holdings PLC Raises Stock Position in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Hsbc Holdings PLC raised its stake in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 66.6% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 38,690 shares of the company's stock after buying an adMay 6, 2025 | marketbeat.comInvesco Ltd. Has $1.46 Million Holdings in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Invesco Ltd. cut its holdings in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 63.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 56,691 shares of the company's stock after sellinMay 3, 2025 | marketbeat.comTower Research Capital LLC TRC Has $495,000 Holdings in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Tower Research Capital LLC TRC raised its position in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 338.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 19,242 shares of tMay 2, 2025 | marketbeat.comIDEAYA Biosciences (IDYA) Projected to Post Quarterly Earnings on TuesdayIDEAYA Biosciences (NASDAQ:IDYA) will be releasing its Q1 2025 earnings before the market opens on Tuesday, May 6. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-6-ideaya-biosciences-inc-stock/)May 1, 2025 | marketbeat.comAquatic Capital Management LLC Buys 29,189 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Aquatic Capital Management LLC lifted its stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 47.1% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 91,189 shares of the coMay 1, 2025 | marketbeat.comPrice T Rowe Associates Inc. MD Lowers Stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Price T Rowe Associates Inc. MD decreased its position in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 3.7% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 3,866,908 shares of the company's stock after selling 148,390 shares during tApril 30, 2025 | marketbeat.comBarclays PLC Boosts Stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Barclays PLC lifted its holdings in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 9.7% during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 198,756 shares of the company's stock after buying an additional 17,586 sApril 29, 2025 | marketbeat.comIDEAYA Biosciences to Participate in Upcoming May 2025 Investor Relations EventsApril 28, 2025 | prnewswire.comAdage Capital Partners GP L.L.C. Has $30.84 Million Stock Position in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Adage Capital Partners GP L.L.C. boosted its holdings in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 22.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,200,094 shares of tApril 28, 2025 | marketbeat.comIDEAYA Biosciences Grants Stock Options To New Employees Under 2023 Inducement PlanApril 27, 2025 | nasdaq.comGuggenheim Capital LLC Takes Position in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Guggenheim Capital LLC acquired a new stake in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 31,389 shares of the companApril 26, 2025 | marketbeat.comIDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)April 25, 2025 | prnewswire.comMarshall Wace LLP Buys 60,361 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Marshall Wace LLP raised its stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 23.9% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 312,666 shares of the company's stock after acquiringApril 25, 2025 | marketbeat.comWalleye Capital LLC Has $548,000 Stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Walleye Capital LLC cut its position in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 84.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 21,312 shares of the company's stock after seApril 25, 2025 | marketbeat.comIDEAYA Biosciences (NASDAQ:IDYA) Trading Up 4.8% - What's Next?IDEAYA Biosciences (NASDAQ:IDYA) Trading 4.8% Higher - Here's What HappenedApril 23, 2025 | marketbeat.comRenaissance Technologies LLC Purchases 113,902 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Renaissance Technologies LLC increased its holdings in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 66.9% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 284,267 shares of the company'sApril 21, 2025 | marketbeat.comIDEAYA Biosciences, Inc. (NASDAQ:IDYA) Given Consensus Recommendation of "Moderate Buy" by AnalystsShares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the fifteen ratings firms that are currently covering the firm, MarketBeat.com reports. Two analysts have rated the stock with a hold recommendation, twelve have isApril 21, 2025 | marketbeat.comJump Financial LLC Has $2.95 Million Holdings in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Jump Financial LLC grew its stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 64.5% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 114,902 shares of the company's stock after purchasing an additional 4April 20, 2025 | marketbeat.comJPMorgan Chase & Co. Has $7.06 Million Holdings in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)JPMorgan Chase & Co. increased its position in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 244.3% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 274,693 shares of the company's stock after buying anApril 19, 2025 | marketbeat.comIdeaya Biosciences: These Prices Are Probably Going To Look Cheap Sooner Than LaterApril 16, 2025 | seekingalpha.comMizuho Securities Sticks to Its Buy Rating for IDEAYA Biosciences (IDYA)April 16, 2025 | markets.businessinsider.comIdeaya Biosciences announces FDA Type D meeting for darovasertib trial designApril 15, 2025 | markets.businessinsider.comIdeaya trial design consisent with guidance, says OppenheimerApril 15, 2025 | markets.businessinsider.comGeode Capital Management LLC Acquires 43,226 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Geode Capital Management LLC increased its stake in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 2.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,988,681 shares of the company's stock after acqApril 15, 2025 | marketbeat.comIDEAYA Biosciences Announces Successful FDA Type D Meeting on Phase 3 Registrational Trial Design for Darovasertib as Neoadjuvant Therapy for Primary Uveal MelanomaApril 14, 2025 | prnewswire.com Get IDEAYA Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for IDYA and its competitors with MarketBeat's FREE daily newsletter. Email Address IDYA Media Mentions By Week IDYA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IDYA News Sentiment▼1.040.79▲Average Medical News Sentiment IDYA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IDYA Articles This Week▼267▲IDYA Articles Average Week Get IDEAYA Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for IDYA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Elanco Animal Health News Legend Biotech News TG Therapeutics News Telix Pharmaceuticals Limited American Depositary Shares News Verona Pharma News Lantheus News Axsome Therapeutics News Grifols News Nuvalent News ADMA Biologics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IDYA) was last updated on 5/16/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored🚨 Nvidia Just Inked a $7B AI Deal—This Could Change EverythingOn Wednesday, Nvidia stock surged—again. Why? Because Saudi Arabia just announced a multi-billion-dollar AI...Timothy Sykes | SponsoredCan This System Really Predict Stocks to the Day?Imagine foreseeing a 30% stock jump — to the day — weeks before it happens. Introducing a new way to predict t...InvestorPlace | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredLenin was right all along… It’s not often you hear praise for a Bolshevik from a veteran investor… but Porter Stansberry says Lenin got o...Porter & Company | SponsoredPrepare now for May 31 eventMUST SEE: Elon Musk's latest project He's one of the most controversial men on the planet. But the Tesla fo...Stansberry Research | Sponsored“America is running out of power” - The Washington PostAccording to The Washington Post, AI is causing America to “run out of power”... It’s true — utility compan...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IDEAYA Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IDEAYA Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy IDYA Stock Free IDYA Stock Alerts